# US 2024/0299330 A1 · Mct formulations for improving cognitive functions and methods of making and using such formulations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0299330 A1
- Document ID: US20240299330A1
- Status: Published application
- Kind: A1
- Application number: 18/005,990
- Filed: 2021-07-20
- Published: 2024-09-12
- Earliest claimed: 2020-07-23
- Assignees: Societe des Produits Nestle S.A.
- Applicants: Societe Des Produits Nestle S.A.
- Inventors: NANCY STEVENSON
- Web page: https://patentgrep.com/patent/US20240299330A1

## CPC

- A23D 7/003: {Compositions other than spreads (characterised by ingredients other than fatty acid triglycerides A23D7/0053)}
- A61K 31/23: of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A23D 7/001: {Spread compositions (characterised by ingredients other than fatty acid triglycerides A23D7/0056)}
- A23D 7/0053: {Compositions other than spreads}
- A23D 7/0056: {Spread compositions}
- A23D 9/007: characterised by ingredients other than fatty acid triglycerides
- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A23L 33/12: Fatty acids or derivatives thereof
- A23L 33/21: Addition of substantially indigestible substances, e.g. dietary fibres
- A23L 33/24: Cellulose or derivatives thereof
- A23L 35/10: {Emulsified foodstuffs}
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K 47/38: Cellulose; Derivatives thereof
- A23V 2200/302: having a modulating effect on age
- A23V 2200/322: having an effect on the health of the nervous system or on mental function
- A23V 2250/1878: Medium-chain fatty acids
- A23D: EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS (preservation thereof A23B20/00; production, refinement or preservation of animal or vegetable fats or oils C11B, C11C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present disclosure provides compositions containing medium chain triglycerides (MCTs) and also containing a food matrix into which at least a portion of the MCTs are formulated. The compositions include specific gums which provide stability and good mouthfeel. The compositions can improve cognitive functioning, support memory and/or recall, provide energy and/or ketones to the brain, and/or prevent and/or treat mild cognitive impairment (MCI).

## Claims

### Claim 1

A composition comprising:
medium chain triglycerides (MCTs) comprising from about 51 wt % to about 90 wt % of octanoic acid; and
at least one gum selected from the group consisting of xanthan gum, gellan gum, carrageenan (iota), carboxymethyl cellulose (CMC), and microcrystalline cellulose (MCC).

### Claim 2 (depends on 1)

The composition of claim 1, wherein the at least one gum comprises gellan gum and iota carrageenan.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the at least one gum comprises at least one of carboxymethyl cellulose (CMC) or microcrystalline cellulose (MCC).

### Claim at position 4

4-9. (canceled)

### Claim 10 (depends on 1)

The composition of claim 1, wherein the composition further comprises at least 4 g protein/100 g of the composition.

### Claim 11 (depends on 1)

The composition of claim 1, wherein the composition further comprises proteins in a weight ratio of at least 0.1 g protein/1.0 g of the MCTs.

### Claim 12 (depends on 1)

The composition of claim 1, wherein the composition further comprises at least one ingredient selected from the group comprising (i) carbohydrates in a weight ratio of at least 0.1 g carbohydrate/1.0 g of the MCTs and (ii) lipids, other than the MCTs, in a weight ratio of at least 0.1 g lipids/1.0 g of the MCTs.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the composition has a pH from about 6.6 to about 7.5.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the composition is in a form selected from the group consisting of a beverage, mayonnaise, salad dressing, margarine, low-fat spread, dairy product, cheese spread, processed cheese, dairy dessert, flavoured milk, cream, fermented milk product, cheese, butter, condensed milk product, ice cream mix, soya product, pasteurised liquid egg, bakery product, confectionary product, confectionary bar, chocolate bar, high fat bar, liquid emulsion, spray-dried powder, freeze-dried powder, UHT pudding, pasteurised pudding, gel, jelly, yoghurt, a food with a fat-based or water-containing filling, and combinations thereof.

### Claim at position 10

15-16. (canceled)

### Claim 17

A method of improving sedimentation and/or mouthfeel attributes of a composition comprising medium chain triglycerides (MCTs), the method comprising:
providing to the composition at least one gum selected from the group consisting of xanthan gum, gellan gum, carrageenan (iota), carboxymethyl cellulose (CMC), and microcrystalline cellulose (MCC).

### Claim 18 (depends on 17)

The method of claim 17, wherein the at least one gum comprises gellan gum and carrageenan iota.

### Claim 19 (depends on 17)

The method of claim 17, wherein the at least one gum comprises at least one of carboxymethyl cellulose (CMC) or microcrystalline cellulose (MCC).

### Claim at position 14

20-23. (canceled)

### Claim 24 (depends on 17)

The method of claim 17, wherein the composition further comprises at least 1 wt % milk protein concentrate (MPC).

### Claim at position 16

25-28. (canceled)

### Claim 29

A method of improving cognitive functioning comprising at least one of episodic memory, executive function, or language skills of an individual in need thereof, the method comprising administering to the individual a composition comprising medium chain triglycerides (MCTs) and at least one gum selected from the group consisting of xanthan gum, gellan gum, carrageenan (iota), carboxymethyl cellulose (CMC), and microcrystalline cellulose (MCC).

### Claim at position 18

30-32. (canceled)

### Claim 33 (depends on 29)

The method of claim 29, wherein the at least one gum comprises gellan gum and iota carrageenan.

### Claim 34

(canceled)

### Claim 35 (depends on 29)

The method of claim 29, wherein the at least one gum comprises about 15 wt % carboxymethyl cellulose (CMC) and about 85 wt % microcrystalline cellulose (MCC).

### Claim 36 (depends on 29)

The method of claim 29, wherein the composition is administered to the individual in a serving that provides at least about 5 g MCTs.

### Claim 37

(canceled)

### Claim 38 (depends on 29)

The method of claim 29, wherein the MCTs comprises from about 51 wt % to about 90 wt % of octanoic acid.

### Claim at position 25

39-42. (canceled)

### Claim 43 (depends on 29)

The method of claim 29, wherein the individual suffers from at least one of deficit in memory, impaired thinking skill comprising inability to make sound decisions and poor judgment, depression, or anxiety.

### Claim 44 (depends on 29)

The method of claim 29, wherein the individual has or suffers from a brain energy deficiency condition or disease, neurological condition, and/or cognitive impairment.

### Claim 45 (depends on 29)

The method of claim 29, wherein the individual has a condition selected from the group consisting of epilepsy, a neurological disease, a neurodegenerative disease, heart failure, inborn errors of metabolism, obesity, types 2 diabetes, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), cancer, a brain energy deficiency condition, a migraine, a memory disorder, an age-related memory disorder, a brain injury, a stroke, amyloid lateral sclerosis, multiple sclerosis, cognitive impairment, mild cognitive impairment (MCI), cognitive impairment post-intensive care, age-induced cognition impairment, Alzheimer's disease, Parkinson's disease, Huntingdon's disease, an inherited metabolic disorder, bipolar disorder, schizophrenia, and combinations thereof.
